VERVE THERAPEUTICS INC. - COMMON STOCK

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

29 11 2024 15:05:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

05 11 2024 06:00:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 11 2024 15:26:49 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 10 2024 15:05:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 9 2024 15:05:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

08 8 2024 06:00:01 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

02 8 2024 15:05:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 7 2024 15:05:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

28 6 2024 06:00:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

31 5 2024 15:01:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Leadership Update

31 5 2024 06:00:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics to Participate in Upcoming Investor Conferences

30 5 2024 15:01:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

08 5 2024 06:00:01 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Dosing of First Patient in Heart-2 Phase 1b Clinical Trial Evaluating VERVE-102

07 5 2024 06:00:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 5 2024 15:01:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Updates on its PCSK9 Program

02 4 2024 06:00:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

28 3 2024 15:51:34 提供 Nasdaq GlobeNewswire

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

01 3 2024 15:01:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

27 2 2024 06:30:00 提供 Nasdaq GlobeNewswire

Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 2 2024 05:30:00 提供 Nasdaq GlobeNewswire